Potential HIV pharma hit

I struggle with biotech. It is out of my area of knowledge, so I can’t relate to it or personally evaluate the pros/cons. It makes me much more of a spectator, following with limited information. I want to be in biotech, to help moderate the sector focus my portfolio has on Internet hardware/software/services companies, but my accuracy on medical stocks stinks. But it seems like even the “experts” have poor accuracy in biotech, so maybe a basket approach would be better. Or just skip it and get more comfortable with the sector risk in being heavily weighted in what I know better.

Justin